Xinhua medical: the non-public offering of shares was approved by Shandong SASAC
Financial Associated Press, January 14 (Xinhua medical announcement). On January 14, 2022, the company received a notice from the controlling shareholder Shandong Yiyang Health Industry Development Group Co., Ltd. ("Shandong health"), and Shandong SASAC has made the reply on the non-public offering of shares of Shandong Xinhua medical device Co., Ltd. (luguzyizi [2022] No. 1), It is agreed that Xinhua medical will issue no more than 121928427 shares in a non-public manner. After the issuance, the total share capital of Xinhua medical will not exceed 528356518 shares, of which Shandong health will hold no more than 152008170 shares, with a shareholding ratio of no less than 28.77%.
This text is a result of machine translation.
Related companies：
Briefing Jun 27, 2022 10:35 AM
· Consumer Staples
Huayou cobalt industry: the company has entered the industry chain of global head power batteries such as Ningde times and LG Chemical
In-depth
Jan 06, 2023 08:30 AM
Jan 05, 2023 07:33 PM
Nov 16, 2022 05:19 PM
Nov 10, 2022 02:39 PM
Technology
Semiconductor Company iSABers materials Completes Over $220 Million Series A++ Financing
iSABers materials (Chinese: 青禾晶元), a semiconductor materials bonding and integration technology company, announced that it has completed a Series A++ financing round totaling RMB 220 million.
May 27, 2023 12:59 AM
Technology
Wisson Tech Releases Draco MH3000 Flexible Composite Robot
Wisson Tech(Chinese: 万勋科技), a provider of interactive service robotics solutions, recently announced the Draco MH3000 flexible composite robot, based on its proprietary flexible robotics technology (Pliabot).
May 26, 2023 11:14 PM
Briefing Dec 03, 2021 08:39 AM
· Consumer Staples
Qualcomm enters the game console market and promotes the development kit with thunder snake
Briefing Nov 03, 2021 02:28 PM
· Consumer Staples
China free: physical store sales returned to normal in September
Technology
Chinese Internet Tech Firm NetEase’s Revenue Rises 6.3% YoY, Reaching CNY 25 Bn in Q1 2023
NetEase continues to invest in self-research key technologies such as AI big models this quarter, with R&D investment of CNY 3.7 billion, accounting for 15% of the total revenue.
May 26, 2023 04:07 PM
Briefing Jul 21, 2021 09:36 PM
· Financials
In the second quarter, the public fund's heavy position stocks are released, and Guizhou Maotai is still the largest heavy position stocks
See more
Read next
Insight
In-depth
Insight
In-depth
Consumer Discretionary, Industrials, Consumer Staples · Analysis
TOPS in Shanghai: The New Trends in the Pet Industry's Overseas Expansion
May 12, 2023 01:33 PM